Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13.1 AUD | -1.98% | +0.50% | +1.98% |
Apr. 02 | Morgans Financial Downgrades ALS to Hold from Add, Price Target at AU$13.70 | MT |
Mar. 26 | Jarden Adjusts ALS's Price Target to AU$13.70 from AU$13.80, Keeps at Buy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.98% | 4.21B | |
+10.39% | 67.5B | |
+11.08% | 18.12B | |
+9.63% | 13.4B | |
+19.46% | 13.28B | |
+16.53% | 9.97B | |
-33.68% | 5.7B | |
-11.58% | 5.53B | |
-3.85% | 4.92B | |
-4.99% | 4.86B |
- Stock Market
- Equities
- ALQ Stock
- News ALS Limited
- ALS : Acquires 49% Stake in European Pharmaceutical Testing Firm Nuvisan